According to the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation, patients with heart failure are classified into: heart failure with reduced ejection fraction (HFrEF, LVEF ...

XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose adjusted budiodarone for the treatment of atrial fibrillation (AF), ...

While some wearables may be tailor made for trial use, they face challenges translating to real-world patient applications outside of a stringent trial setting, and vice versa. This creates a unique ...

Timely recognition of symptoms like chest pain, breathlessness, syncope, palpitations, or sudden neurological deficits can dramatically alter outcomes in cardiovascular emergencies. Delays, even minor ...

Accurate cardiac output (CO) measurements during exercise are essential for the diagnosis of exercise pulmonary hypertension (PH), exercise precapillary PH, and exercise postcapillary PH. The purpose ...

Abstract: This study presents a novel non-contact approach for cardiac output (CO) monitoring via facial photoplethysmography (PPG), with a focus on advancing hemodynamic assessment during intravenous ...

ABSTRACT: Fluid therapy has evolved dramatically from its origins in 17th-century blood transfusion experiments to sophisticated, modern, perioperative fluid management protocols. This comprehensive ...

For children with adenotonsillar hypertrophy (ATH) and obstructive sleep-disordered breathing (OSDB), adenotonsillectomy is associated with a significant reduction in resting heart rate and estimated ...

Solution combines ARTELLA’s platform with VivaLink’s medical grade wearable ECG monitors. Artella Solutions Inc. (“ARTELLA”), a digital healthcare company delivering real-time cardiac monitoring ...